Aptuit, LLC has acquired Kuecept Ltd, a company offering support services for pharmaceutical development, based in London, to enhance Aptuit’s position in drug pre-formulation, formulation prototyping, and formulation development services.

Kuecept offers technical expertise in services supporting preclinical drug development. Kuecept provides pre-formulation testing, preclinical dose-vehicle screening, and formulation development. These are complemented by a range of enabling drug-delivery technologies. Kuecept has experience in respiratory, parenteral and oral formulation development for insoluble compounds.

Source: Aptuit